INTRODUCTION
============

Already at the beginning of the 18th century, long before the term \"allergy\" was coined by Clemens von Pirquet, fungal exposure was recognized as a potential cause of adverse respiratory symptoms.[@B1] In 1726, Sir Floyer reported for the first time a severe asthma attack in a patient who had visited a wine cellar where must was fermenting.[@B2] More than 100 years later, Blackley described bronchial catarrh and chest tightness after inhalation of *Penicillium glaucum spores*.[@B3] In 1924, Storm van Leeuwen suggested that inhaled fungal spores could cause asthma.

Although the first observation of fungal allergy dates back 300 years, the association between exposure to fungi and the occurrence of allergic symptoms has been discussed controversially for a long time, and indeed fungi are still a neglected allergen source.[@B4],[@B5],[@B6] Nowadays, data from several epidemiological studies provide evidence for the important role of fungi in respiratory disease in the indoor as well as in the outdoor environment. Fungal sensitization is not only found more often in patients with asthma but also may represent a risk factor for development of asthma.[@B7],[@B8] Moldy odor, home dampness and visible mould growth have been associated with the development of asthma and the severity of respiratory symptoms in children.[@B9] Indoor exposure to fungi was further found to be a risk factor for the prevalence of coughing, increased peak expiratory flow variability, and asthma.[@B10],[@B11],[@B12],[@B13],[@B14] A correlation was found between spore levels and the occurrence of hospital delivery and asthma treatment, but also with asthma-related death. In Chicago, for example, death from asthma was about twice as common on days with a high total mold spore count as on days with lower spore counts.[@B15] In rural areas, respiratory symptoms have been linked to increased amounts of spores during crop ripening, harvest, and storage.[@B16],[@B17],[@B18] Furthermore, thunderstorm-related asthma was found to be associated with increased spore concentrations of fungal species from Ascomycota and Basidiomycota.[@B19]

The importance of molds to induce IgE-mediated reactions was demonstrated by IgE binding experiments, the ability to induce histamine release in basophils from sensitized patients and by skin testing.[@B20],[@B21],[@B22],[@B23] Bronchial and nasal challenge tests with extracts of fungal spores or mycel were able to induce rhinitis, asthma,[@B23],[@B24] and late phase reactions including eosinophilic infiltration.[@B25],[@B26] The fact that extracts of spores and mycel are able to efficiently induce allergic symptoms provided evidence that relevant allergens are present in both spores and mycel.[@B22],[@B23] For Alt a 1, the major *Alternaria alternata* allergen, the presence in spores and mycel has further been demonstrated by immunogold electron microscopy.[@B27],[@B28],[@B29] Interestingly, fungi also activate the innate immune system and may enhance inflammation caused by unrelated allergens (e.g., grass pollen).[@B30],[@B31],[@B32]

A prerequisite for the development of allergic sensitization is that individuals are exposed to the allergen source in clinically relevant amounts. Fungal spores are an ever present component of the atmosphere,[@B18] constituting the largest proportion of aerobiological particles in our environment[@B33] which even exceeds the concentration of pollen grains.[@B17] Due to the large spectrum of mold species and the difficulty in identifying them our knowledge of outdoor atmospheric mold spores and their relevance in allergic disease is still incomplete. A recent study identified a set of 40 potentially allergy-inducing genera in air samples collected in Korea.[@B34]

Using DNA analysis differences in the relative abundance and seasonal cycles of various groups of fungi in coarse and fine particulate matter were found, with more plant pathogens in the coarse fraction and more human pathogens and allergens in the respirable fine particle fraction (\<3 micron).[@B35]

The number of fungal spores in the atmosphere underlies seasonal as well as interdural variations. Especially climatic factors (temperature, rainfall, relative humidity, and wind) and circadian patterns (darkness and sunlight) influence the spectrum of fungal species and their concentrations in the environment.[@B16],[@B33],[@B36],[@B37] The number of spores in the air rises in particular in late summer and early autumn, when nutritional sources are available, while they diminish in winter ([Fig. 1](#F1){ref-type="fig"}).[@B16],[@B37] Considering daily fluctuations, the highest spore counts can be found in the afternoon and early evening.[@B16]

In general, exposure to fungi occurs via inhalation, skin contact, or ingestion.[@B38] The inhalative route is with regard to respiratory symptoms the most important one. Fungal spores show a broad spectrum of different shapes and sizes, ranging from less than 2 to 250 µm. A substantial proportion of spores are small enough to penetrate into the lower airways. The threshold level necessary to elicit allergic symptoms in sensitized patients is not known and varies between different species. Spore concentrations of *Alternaria* equal or greater than 100 spores/m^3^ are believed to evoke allergic symptoms,[@B39] whereas the reference value for *Cladosporium* is estimated to be 3,000 spores/m^3^.[@B18],[@B33] However, for 2 reasons the determination of spore concentrations is not a perfect method to quantify the exposure of a sensitized individual. Using a Halogen Immunoassay (HIA), it was shown that fungal fragments and submicron particles of intra- and extracellular fungal structures contain detectable amounts of allergens and may therefore function as aeroallergen sources.[@B40] These particles are present in considerable larger quantities than spores, and respiratory deposition models indicate for some fungal species a much higher burden caused by fragments than by spores.[@B41] Second, there is evidence that airborne allergen levels do not always correspond to spore or particle counts.[@B42],[@B43] For example, it has been shown that depending on the developmental status, spores from *Alternaria alternata* release different amounts of the major allergen Alt a 1.[@B44]

Prevalence of sensitization
---------------------------

Fungi are ubiquitous and, as a consequence of this, sensitization to fungi can be found throughout the world ([Fig. 2](#F2){ref-type="fig"}). The exact prevalence of mold sensitization is not known but is estimated to range from 3% to 10% in the general population. Likewise, the prevalence of sensitization in atopic patients varies depending on many factors as it was exemplified in several large studies.[@B45],[@B46],[@B47],[@B48],[@B49] A multicenter study in 7 European countries investigated the prevalence of *Alternaria* and *Cladosporium* sensitization in 877 children and adults (5-60 years) with rhinits and/or asthma. From these, approximately 9.5% were skin prick positive to at least one or both fungal species. The highest prevalence was found in Spain (20%), the lowest in Portugal (3%).[@B50] In another very recent multinational study (EPAAC, Early Prevention of Asthma in Atopic Children) conducted in 10 European countries, Australia, and South Africa, specific IgE antibodies to food and aeroallergens were determined in 2,184 infants (mean age: 17.6 months) with atopic eczema. The overall sensitization rate to *Alternaria* in this population was 3.7%, but variations were observed between the different countries. Children from Australia showed the highest sensitization rate (7%), whereas in Belgium no sensitization to *Alternaria* was found.[@B51] The third National Health and Nutrition Examination Survey in the USA revealed that approximately 12.9% of the population (6-59 years) showed positive skin prick results to Alternaria alternata.[@B52] A survey performed by Global Allergy and Asthma European Network in 16 European countries showed general sensitization rates of 11.9% for *Alternaria alternata* and 5.8% for *Cladosporium herbarum* with the highest prevalence in the UK, Ireland, and Northern Europe.[@B45] A study performed with atopic patients in a tropic environment demonstrated the importance of sensitization to basidiomycete *Ganoderma applanatum* with the prevalence of 30%.[@B53] In those studies, populations from different countries have been investigated that varied in age and clinical manifestations of allergy. Thus, it seems that demographic and epidemiological factors contribute to varying prevalence data. Based on studies that consider the age of patients in the evaluation of prevalence data, it was assumed that sensitization to fungi is an age-dependent process with a higher prevalence in children.[@B11],[@B51],[@B52],[@B53],[@B54],[@B55],[@B56],[@B57] It was further shown for allergy to the species *Alternaria* that the course of the disease differed markedly from allergies to other common aeroallergens.[@B58] *Alternaria*-specific IgE antibodies increase significantly in early childhood until they reach a maximum level and then seem to decline again with increasing age.[@B11],[@B55],[@B56],[@B57],[@B58] In contrast to this, specific IgE antibodies to house dust mite increase with age and remain constantly high during childhood.[@B11] It is interesting that monosensitization to fungi is quite rare and that specific IgE to fungi are often associated with the presence of specific IgE to other aeroallergens.[@B54],[@B59] So far, the reason for this polysensitization in connection with fungal sensitization is not known. A study in 6,840 Italian children pointed also at the influence of genetic factors, as 82.9% of mold-sensitized children had a positive family history of mold allergy.[@B59]

The varying prevalences of mold sensitization may also be ascribed to methodological limitations. Current methods for identification of mold species rely especially on morphological characteristics of spores, so they are time-consuming and require the skills of a trained person. As only a small number of mold species have been identified, sensitization to unknown fungi remains elusive. Furthermore, one has to be aware of the fact that results of skin tests and *in vitro* measurements of specific IgE antibodies are often not directly comparable.[@B57],[@B60],[@B61] Finally, fungal allergen extracts used for diagnostic testing are of poor quality and show high variability regarding allergen contents.[@B62] Although at present the prevalence of sensitization to fungi can only be estimated, many studies identify fungi as an important cause of respiratory allergy.

Fungal allergens
----------------

It has been estimated that around 1 to 1.5 million fungal species exist worldwide, but so far only 80,000 have been described. From these, 112 genera are thought to be a source of allergens. The 4 genera most commonly associated with the development of allergy are *Alternaria*,[@B54] *Cladosporium*, *Penicillium*, and *Aspergillus*. These genera belong to the phyllum Ascomycota, but allergens have also been described from Basidiomycota and Zygomycota. Overall, 107 allergens from 28 fungal genera have been approved by the International Allergen Nomenclature Sub-committee (<http://www.allergen.org/>, [Fig. 3](#F3){ref-type="fig"}), but many fungal proteins have been shown to be IgE-reactive. Bowyer et al.[@B38] estimated that the most thoroughly studied allergenic fungi have up to 20 well characterized allergens and further 27 to 60 other less well characterized IgE binding proteins. Recently, it was shown that IgE sensitization to fungal species reflected well their phylogenetic relationship since IgE reactivity correlated better in closely related molds compared to phylogenetically distant molds.[@B63] [Supplementary Table 1](#S1){ref-type="supplementary-material"} summarizes known fungal allergens and gives an overview on their biological function, their prevalence of IgE recognition, and their cross-reactivity.

Although molds produce a great variety of IgE-binding molecules, not all of them are equally important. The first factor that determines the importance of an allergen is the prevalence of recognition among patients sensitized to the allergen source. Based on this, an allergen can be classified as major (\>50%) or minor (\<50%) allergen. However, it is known that IgE reactivity of an allergen does not necessarily reflect its capacity to induce allergic symptoms. Determination of the IgE-binding capacity is therefore not sufficient for assessing the clinical relevance of an allergen. It is rather the capability to induce strong IgE-mediated and T cell-mediated reactions that define the clinical relevance. The ability of an allergen to induce IgE-mediated reactions can be assessed by *in vitro* (basophil histamine release) and *in vivo* tests (skin and provocation tests). Additionally, T-cell proliferation assays (*in vitro*) and the atopy patch test (*in vivo*) allow inferences on T cell-mediated processes.

The clinical relevance is further dictated by the frequency of the allergen\'s occurrence and the amount of allergen liberated by a mold species. Molds and fragments thereof are not only a constant component of our environment, but under certain conditions that favor their growth (*i.e.* moisture, poor ventilation, *etc*.) exposure may be exceptionally high. Antibody probes against mold allergens are useful tools to determine the presence of a certain fungus and to measure the personal allergen exposure.

The molecular nature of fungal allergens
----------------------------------------

Knowledge about the sequence and structure of an allergen forms the basis for the understanding of its immunological and biological properties and ultimately is essential for the development of new forms of diagnosis and treatment.[@B64] To study these characteristics, the allergen needs to be available with a high degree of purity. First allergen characterizations were carried out on natural allergens isolated from allergen extracts, but complex and tedious purification processes hampered such analysis for many allergen sources. With the introduction of recombinant DNA technology into the field of allergology, an ongoing progress in allergen characterization started more than 25 years ago. Today, many mold allergens have already been cloned ([Supplementary Table 1](#S1){ref-type="supplementary-material"}) and are available as recombinant proteins. The amino acid sequence of an allergen determines its physiochemical characteristics and forms the basis of the secondary and tertiary structures. So far, the 3 dimensional structures of some mold allergens have been solved by X-ray crystallography.[@B65],[@B66],[@B67],[@B68],[@B69],[@B70] Computational structure prediction programs in principle allow predictions of the allergen\'s conformation based on the amino acid sequence. Knowledge of the sequence further facilitates the identification of amino acids involved in IgE binding and T-cell activation.[@B71] Currently increasing numbers of B and T-cell epitopes of allergens from different mould species are determined.[@B72],[@B73]

Furthermore, the knowledge about similarities in sequence and conformation also permits the identification of homologous proteins in related and unrelated species, which might have cross-reactive potential. However, one has to be aware of the fact that the degree of sequence identity between an allergen and a homologous protein does not necessarily predict cross-reactivity. Overall, cross-reactivity between proteins can be due to common moieties in the protein sequence or to common carbohydrate structures (CCD, cross-reactive carbohydrate determinant). It can thus occur between proteins from taxonomically related, but also from distantly or non-related sources. Hence, cross-reactivity has been found within 1 fungal phylum, between different fungal phyla and also to non-fungal allergens of other allergen sources[@B74] and even to human proteins. The most prominent examples of cross-reactive fungal allergens are enolases,[@B75],[@B76],[@B77] manganese superoxide dismutases (MnSOD),[@B78] cyclophilins,[@B66],[@B79],[@B80] glutathione-S-transferases,[@B81] thioredoxins,[@B67],[@B82] and transaldolases.[@B83] Beside these, serine proteases, ribosomal proteins, heat shock proteins, and peroxisomal proteins have found to be cross-reactive (see [supplementary Table 1](#S1){ref-type="supplementary-material"}). Clinically, cross-reactive molecules are responsible for IgE-mediated reactions to a variety of allergen sources. Cross-reactive molecules with poor allergenic activity (*e.g.*, CCDs) can influence the accuracy of diagnosis since tests based on IgE binding give positive results that do not reflect the clinical importance of the allergens. In addition, the relevance of CCDs in eliciting IgE-mediated reactions is still a matter of controversy and, although many mold species produce glycosylated proteins that bind IgE *in vitro*, it is not clear whether the carbohydrate moiety contributes to the allergenicity of the molecule. The lack of biological activity might be due to a limited epitope valency of carbohydrates and/or a low affinity of IgE antibodies for the corresponding glycan epitope.[@B84],[@B85] In case of plant carbohydrates, structures that are crucial for IgE antibody binding have been determined: asparagine-linked xylose and fucose residues are mainly responsible for structural similarities which cause cross-reactivity.[@B84],[@B85] In contrast to plant carbohydrates, mold proteins are highly mannosylated, indicating that plant and fungal CCDs are not cross-reactive; however, further research is required to address this issue.

Knowledge about an allergen\'s sequence can give information regarding the biological and biochemical properties of a protein. Since molds are heterotrophic organisms, they are dependent on organic nutrients provided by other organisms. They digest their food externally, excreting enzymes into the environment.[@B33] It is therefore not surprising that many fungal allergens have enzymatic functions. However, enzymatic activity may also have an influence on the allergenicity of an allergen source. First, proteases of fungal extracts were shown to have Th2-inducing properties[@B86] either by facilitating antigen access through cleavage of tight junction proteins[@B87] or through direct activation of epithelial cells.[@B87],[@B88],[@B89],[@B90],[@B91],[@B92],[@B93] Second, degradation processes can impair the stability of other allergens present in an allergen source.

To summarize, the knowledge regarding the structures, immunological and biological properties of mold allergens is increasing, but there is a need for the systematic evaluation of the prevalence of IgE recognition of individual allergens in population studies and of the allergenic activity of allergens to determine their clinical relevance. Only on the basis of such systematic studies, new forms of diagnosis and therapy can be developed.

Precise diagnosis of fungal allergy is the basis for immunotherapy
------------------------------------------------------------------

The first and most important step toward efficient allergen-specific forms of treatment is the proper diagnosis of mold sensitization and the evaluation of the clinical relevance of the sensitizing allergens. Diagnosis of allergies, as routinely performed today, is a stepwise process, including anamnesis, determination of total and allergen-specific IgE antibodies, skin tests and, if necessary, other provocation tests.[@B94] Anamnesis plays a decisive role in the diagnosis of allergy and usually guides further diagnostic steps, such as serological testing and provocation testing. However, if fungal allergy is not considered, it may be easily overlooked because fungal allergens often co-occur with other frequent indoor (e.g., house dust mites, animal dander) and outdoor allergens (grass and weed pollen). In fact, many of the mold-sensitized patients have also specific IgE antibodies to other inhalant allergen sources, and peak spore levels overlap with grass and weed pollen season, so mold sensitization might be masked by other allergies ([Fig. 4](#F4){ref-type="fig"}).

Allergen-specific IgE antibodies and their clinical relevance are basically determined by serological investigations and skin tests. In general, skin tests are more commonly found to correlate with clinical symptoms of allergy and are regarded as the more sensitive tests, whereas serological investigations are considered more specific.[@B95] A combination of *in vivo* and *in vitro* tests is therefore recommended for a reliable diagnosis of mold allergy.[@B96] A recent study on diagnosis of mold allergy compared the sensitivity of an intradermal skin test with a serum assay for specific IgE antibodies (ImmunoCAP test) and showed impressively the gap between *in vivo* and *in vitro* results. Seventy-five patients with rhinitis were tested with extracts of *Candida*, *Alternaria*, *Cladosporium*, and *Penicillium* for their IgE reactivity. The incidence of a positive test determined by skin tests in comparison to the CAP analysis varied fewest for *Cladosporium* (4-fold) and the most for *Alternaria* (17.5-fold).[@B61] A multicenter study from Spain which determined the prevalence of Alternaria alternata sensitization revealed that in more than one-third of patients, a positive *in vivo* result could not be confirmed with the *in vitro* tests.[@B57]

The discrepancy of diagnostic tests can partly be ascribed to the poor quality of mold extracts.[@B95] Besides intrinsic factors, like strain variabilities[@B97],[@B98],[@B99],[@B100],[@B101],[@B102] and the tendency of molds for spontaneous mutation,[@B103] the raw material (spores/mycelium)[@B20],[@B21],[@B22] and manufacturing processes (culturing conditions, extracting procedures)[@B28],[@B97],[@B99],[@B100],[@B104],[@B105] affect the quality of mold allergen extracts. As molds are enzyme-rich organisms, degradation processes should also not be underestimated.[@B97],[@B99],[@B100],[@B102],[@B104] All these factors may have an impact on the presence of certain allergens, protein/carbohydrate content, and allergenicity and antigenicity of mold extracts.[@B28],[@B97],[@B98],[@B99],[@B100],[@B104],[@B105] Martínez et al.[@B101] reported high variabilities in the expression of the major allergen Alt a 1 in 11 *Alternaria alternata* strains that were cultured under identical conditions. In the same mold species, Sáenz-de-Santamaria et al.[@B102] observed varying enzymatic activities in 14 strains. Portnoy et al.[@B104] revealed that extraction time influences the elution of certain allergens and that a longer extraction interval increases the proportion of carbohydrates. We investigated the influence of mold strains, growth medium, and growth time on the expression of *Alternaria alternata* allergens. Four *Alternaria* strains were cultured for 2 or 4 weeks on 3 media that differed in carbohydrate and protein content as well as in the presence of additional nutrients. The immunblot in [Fig. 5](#F5){ref-type="fig"} displays the enormous impact of the strains, nutritional sources, and growth periods on the prescence of IgE-reactive proteins in the allergen extracts. It also exemplifies the difficulties in defining optimal growth conditions.

Although commercially available allergen solutions have to pass through some company-internal standardization procedures and quality controls, there are until now no generally accepted guidelines for the preparation of allergenic mould extracts. Determination of the protein content and measurement of total IgE activity seem to be unsuitable, as protein concentration might not necessarily be correlated with the allergenicity of the extract, since significant qualitative differences in allergen composition have been described.[@B21],[@B97],[@B98],[@B104] It is therefore not astonishing that considerable differences in potency of mold extracts between manufacturers and even batch-to-batch variations can be found in these so-called \"standardized extracts\".[@B62],[@B97],[@B106] Vailes et al.[@B106] determined the content of Alt a 1 and Asp f 1 in extracts of *Alternaria alternata* and *Aspergillus fumigatus* used for diagnosis in the United States. The extracts were obtained in 2 consecutive years from 8 different manufactures. Whereas Alt a 1 was detectable in all but 1 extract, the amount of Asp f 1 was low or even undetectable in extracts of 4 companies. Furthermore, substantial variations within and between companies were found for Asp f 1. Due to the problems with standardization of mold extracts, only a limited number of them are available for diagnosis. This has certainly contributed to the fact that mold allergy has been underestimated for a long time.

Besides the inconsistency of allergen extracts, the presence of carbohydrates and other cross-reactive components hampers the precise identification of the disease eliciting mold species. Molds are known to contain many glycosylated proteins that might impair diagnostic tests. False positive results due to carbohydrates can be unveiled in *in vivo* provocation tests, since it is assumed that anti-carbohydrate IgE antibodies lack biological relevance. However, cross-reactive allergens from related and unrelated allergen sources distract from the primary sensitizing source. Especially in case of polysensitized patients, diagnosis based on extracts allows no discrimination between co- and cross-sensitization. The need for an improved component-resolved diagnosis is therefore evident, and it is clear that improvement can only come from the use of recombinant mold allergens.

In fact, allergens from different mold species have been cloned and produced as recombinant IgE-reactive proteins (see [supplementary Table 1](#S1){ref-type="supplementary-material"}). For some of them, the ability to induce immediate-type reactions has been demonstrated by basophil histamine release assays and skin prick tests.[@B107],[@B108] Recombinant allergens with similar characteristics as their natural counterpart are suited for *in vitro* and *in vivo* diagnosis. The application of species-specific allergens (like Alt a 1, Asp f 1, Cop c 1, or Mala s 1) allows the identification of genuine sensitization to a single mold species. Recombinant mold allergens with known cross-reactivity are additionally useful tools as marker allergens to identify cross-sensitization. In this way, sensitivity as well as specificity of diagnosis can be improved. This concept has been tested in a small group of patients sensitized to *Alternaria alternata*. A combination of the species-specific major allergen Alt a 1 with the cross-reactive enolase Alt a 6 (formerly Alt a 2) could correctly diagnose sensitization in 7 tested patients.[@B109] Recently, a study including 80 European patients showed that rAlt a 1 can be used to diagnose 98% of patients with allergy to *Alternaria alternata* and that almost all specific IgE in these patients was directed against Alt a 1.[@B72] This finding suggests that Alt a 1 can be used as a reliable diagnostic marker allergen for genuine sensitisation to *Alternaria* and could replace the *Alternaria* extract. However, another study suggested that a recently cloned cross-reactive allergen from *Alternaria alternata*, namely MnSOD, should be included together with Alt a 1 and Alt a 6 in the molecular array for the diagnosis of allergy to Pleosporaceae since 2 out of 30 patients did not react to Alt a 1 nor to Alt a 6, but they showed reactivity to MnSOD.[@B110] In another study, 2 recombinant proteins from *Aspergillus fumigatus*, rAsp f 4 and rAsp f 6, were shown to allow the discrimination between allergic bronchopulmonary aspergillosis and *Aspergillus* sensitization.[@B108] Sensitization to certain mold allergens may also be used to predict the severity of clinical symptoms. *Alternaria alternata sensitized* patients were reported to be affected more frequently by asthma than non-*Alternaria*-sensitized patients.[@B111]

In summary, mold allergy has long been underestimated and occurs more frequently than expected. Since mold allergic patients are often polysensitized, IgE antibodies to other allergen sources might mask mold allergy. Therefore, the precise determination of the disease-causing allergen source is particularly important for mold allergy and is the basis to correctly prescribe the most appropriate specific forms of treatment.

Immunotherapy of mold allergy
-----------------------------

Treatment of allergic disease is based on pharmacotherapy, allergen avoidance and immunotherapy.[@B112] Whereas pharmaceutical drugs like steroids and antihistamines can solely abate the symptoms of allergic disease, allergen avoidance is in case of outdoor exposure difficult to achieve.[@B113] In case of indoor exposure, avoidance is possible under certain conditions, such as visible mold growth.[@B114] Specific immunotherapy would be an antigen-specific, long-lasting and disease-modifying approach for the treatment of mold allergy. In 1998, the WHO published a position paper with guidelines for safe and effective immunotherapy. These guidelines stressed the point that immunotherapy should only be performed with well-defined vaccines in carefully selected patients.[@B112] In case of mold allergy, these criteria are difficult to fulfill and therefore - strictly speaking - immunotherapy is currently not recommended for mold allergic patients. First, mold allergen extracts remain ill-defined mixtures of allergenic and non-allergenic components. They contain a very complex spectrum of proteins, glycoproteins, carbohydrates, and other components that definitely do not contribute to the allergenicity of the whole extract but might lead to impaired diagnostic tests or to side effects during treatment. Second, the selection of patients for immunotherapy is impaired by the fact that many mould allergic patients suffer from asthma and are sensitized to other common inhalant allergens.[@B54] Although immunotherapy has been shown to be effective for the treatment of allergic asthma, especially this group of patients is prone to develop adverse reactions during treatment. Therefore, clinical manifestations of asthma have been considered rather as a contraindication for immunotherapy.[@B115] Nevertheless, studies with mold extracts, predominately *Alternaria* and *Cladosporium* species, have been performed ([Table 1](#T1){ref-type="table"}). We found 6 studies which evaluated the safety of immunotherapy using mold extracts.[@B116],[@B117],[@B118],[@B119],[@B120],[@B121] In 1982, Kaad and Ostergaard treated 38 children with an *Alternaria iridis* extract mixed with a *Cladosporium herbarum* extract over a period of 3.5 years. Nineteen percent of the patients had to stop treatment because of severe side reactions associated with the generation of precipitating serum antibodies.[@B116] Four years later, the same authors reported more severe and even anaphylactic reactions to *Alternaria* and *Cladosporium* extracts than to extracts of grass pollen, animal dander, or house dust mite in asthmatic children resistant to pharmacological treatment. Since 50% of patients had to be withdrawn from treatment, the authors concluded that immunotherapy in asthmatics with mold allergy is not recommended.[@B117] These results were further confirmed by a retrospective study with 83 adults and 46 children with rhinitis and/or bronchial asthma. Using a biologically standardized depot extract of *Alternaria tenuis*, 39.5% of patients experienced adverse reactions which were mainly systemic. Children and patients with asthma were at higher risk of developing side effects.[@B119] Moreno et al.[@B120] investigated the safety of 4 different induction schedules in 108 patients (see [Table 1](#T2){ref-type="table"}). Only a few adverse reactions to an extract of *Alternaria tenuis* were reported which were associated with only 1 induction schedule. Finally, Martínez-Canavate et al.[@B121] compared the tolerance of a conventional short regime to a cluster regime in a pediatric population. Whereas more local reactions were observed in the conventional regime, no significant differences between the 2 regimes were found regarding systemic reactions. In total, 10 (10.6%) out of 94 patients had local or systemic reactions and 1 patient from the cluster regime had to be withdrawn from treatment.

Based on the high incidence of adverse reactions, mold extracts were stated as \"less tolerated\" than other allergen extracts.[@B117],[@B119] Therefore, only a few double-blind, placebo controlled studies have been performed so far that analyze the clinical and immunological efficacy of mold immunotherapy. In 1986, Dreborg et al.[@B122] treated 16 children actively over a period of 10 months with a standardized *Cladosporium herbarum* extract, while 14 children received a histamine placebo. All the children were polysensitized and suffered from rhinoconjunctivits and/or mold-induced asthma. Symptom scores and total medication score remained unchanged in both groups after 6 months of treatment. Although skin reactivity, conjunctival sensitivity, and peak expiratory flow improved, no significant differences were found between the actively treated and placebo groups. However, a significant reduction in bronchial and conjunctival sensitivity as well as a significant decrease in specific IgE antibodies could be observed in the extract-treated group after 10 months of treatment. A drawback was the high frequency of systemic side effects, which occurred in 81% of patients, especially during the peak of mold season.[@B122],[@B123] In a similar approach with *Cladosporium herbarum*, the efficacy of immunotherapy was evaluated in 11 adult asthmatics. After 5 to 7 months of treatment, no differences were found between the active and placebo-treated groups when the symptom and medication score were evaluated separately. A combined evaluation revealed that 81% of the *C. herbarum* treated group and 27% of the placebo control group had unchanged or improved symptoms.[@B124] A significant decrease in bronchial and dermal sensitivity as well as a significant increase in specific IgG~1~ and IgG~4~ antibodies was observed in the actively treated group.[@B125],[@B126] Furthermore, a significant decrease in histamine release was reported from basophils isolated from patients of the actively treated group.[@B127] Local side effects were reported in 70% and systemic reactions in 100% of the *C. herbarum* treated group.[@B124] Immunotherapy with a standardized extract of *Alternaria alternata* resulted in an improved symptom-medication score, an increased tolerance in nasal provocation tests, and reduced skin reactivity in the actively treated group. Specific IgG antibodies increased significantly after 1 year of treatment, specific IgE antibodies did not change in either group.[@B128] Criado Molina et al.[@B129] evaluated the efficacy and safety of immunotherapy with *Alternaria alternata* in a sublingual approach. Nineteen out of 38 patients received over a period of 12 months oral immunotherapy, whereas the control group was symptomatically treated. Eight adverse reactions occurred that were described as mild to moderate. Skin and bronchial reactivity were significantly improved in the actively treated group, and an increase in specific IgG4 antibodies was observed. Peak expiratory flow and specific IgE antibody levels remained unchanged in both groups. Another double-blind, placebo-controlled study was carried out in 2008 and included 28 patients. Fourteen patients were treated with a conventional schedule of subcutaneous immunotherapy, the control group received a histamine placebo. The allergen extract applied was a biologically standardized preparation of *Alternaria alternata*. The highest maintenance dose that induces no systemic side reactions was evaluated in an earlier study before the immunotherapy trial.[@B130] Over a period of 12 months, no local but 2 systemic reactions were reported in asthmatic patients. The major significant improvements for the *Alternaria*-treated group were an increase in peak expiratory flow and a decrease in severity of asthma.[@B131] No changes in nasal or ocular symptoms as well as in medication scores could be observed. Allergen-specific IgE antibodies decreased, whereas antibody titers of total and specific IgG (IgG~1~ and IgG~4~) increased.[@B132] A double-blind, placebo-controlled study included 50 children and adolescents (30 active group, 20 placebo group) with *A. alternata*-related seasonal allergic rhinoconjunctivitis and/or asthma. Standardized *A. alternata* extract were injected over 3 years according to the conventional schedule of subcutaneous immunotherapy. A group that received active therapy resulted in improved quality of life regarding asthma and decreased sensitivity upon nasal challenge. The combined symptom medication score decreased in years 2 (38.7%) and 3 (63.5%) of the study. No severe side effects were observed while mild local reactions were reported in 7 patients.[@B133]

Besides these double-blind, placebo-controlled studies, a few open studies have been performed. Thirty-nine children with rhinitis and/or *Alternaria*-induced asthma were enrolled together with 40 age-matched controls in a prospective immunotherapy study. After 3 years of therapy, all patients in the active group reported clinical improvement in a questionnaire, while the symptoms worsened in 87.5% of control patients. The clinical effect seemed to be dose-dependent as patients receiving higher cumulative doses improved considerably.[@B134] Bernardis et al.[@B39] compared the efficacy of subcutaneous immunotherapy (SIT) to sublingual immunotherapy (SLIT) using an extract of *Alternaria tenuis*. Eleven patients were randomized to the SIT group and 12 to the SLIT group. Although SLIT was very well tolerated, the SIT approach seemed to be more efficient. In both approaches, patients subjectively reported an improvement in symptom medication scores. The threshold to elicit allergic symptoms by nasal provocation test increased in both groups but reached only statistically significance in the SLIT group. However, skin reactivity and IgE levels significantly decreased only in the SIT group, whereas total IgG and specific IgG~4~ levels increased. Nevertheless, side effects occurred in approximately 36.4% of patients treated with SIT. Recently, Kilic et al.[@B135] evaluated efficacy of SIT in 16 children with bronchial asthma monosensitized to *Alternaria* in a prospective, open parallel group-controlled study. After 1 year of treatment with *Alternatia* extracts, a reduction in bronchial responsiveness, a reduction in eosinophil counts in sputum and a decrease in specific IgE levels were found in the actively treated group. In summary, improvements in symptoms have been observed in SIT studies for mold allergy and one can therefore assume that SIT should be effective for mold allergy as it is for many other allergens. However, progress seems to be limited by natural allergen extracts which induce side effects and are of poor quality. It will therefore be necessary to use recombinant mold allergen derivatives with reduced allergenic activity or mold allergen-derived peptides for treatment.

Strategies for the improvement of mold allergy immunotherapy
------------------------------------------------------------

Available data suggests that the insufficient quality of natural mold allergen extracts is the major bottleneck for the development of safe and effective SIT for mold allergy. Especially during the SIT of mold allergy, the occurrence of local and severe systemic side reactions was found to hamper the application of sufficiently high allergen doses needed for efficient therapy (see [Table 1](#T1){ref-type="table"}). Improvements are therefore needed that allow the safe administration of sufficiently high doses. Furthermore, all disease-relevant allergens must be included in vaccines which often cannot be achieved with allergen extracts that lack certain allergens.

### Recombinant allergens

The cDNA sequences of many mold allergens have already been elucidated (see [supplementary Table 1](#S1){ref-type="supplementary-material"}), and by using various expression systems recombinant molecules can be produced in large quantities and high purity. Recombinant wilde-type allergens, which resemble immunologically their natural counterpart, represent valuable tools for specific diagnosis, as they can be used in diagnostic tests to determine the disease-causing allergen source. Using component-resolved diagnosis, relevant recombinant allergens can be selected for allergen SIT. The feasibility of this approach has already been shown in case of grass pollen and birch pollen allergens, but so far recombinant allergens have not yet been evaluated for the treatment of mould allergies.

However, when the use of recombinant wild-type allergens is considered for SIT, one has to be aware that the administration of a recombinant allergen mimicking the characteristics of the natural allergen carries the risk of inducing allergic reactions similar as with allergen extracts. Adverse reaction might particularly pose a problem in case of mold allergy, as many patients suffer from severe symptoms. Therefore, the development of genetically modified allergen variants with reduced allergenic activity (hypoallergenic derivatives) represents a desirable approach.[@B136],[@B137]

### Recombinant hypoallergenic allergen derivatives and peptide-based allergen vaccines

The main strategy behind recombinant hypoallergens is the elimination of IgE reactivity while retaining T-cell reactivity. The disruption of IgE-binding epitopes can be achieved by (1) introduction of point mutations, (2) deletion of IgE reactive parts, (3) fragmentation of allergens, (4) reassembling of allergens in the form of mosaic molecules, (5) oligomerisation of allergens, and (6) chemical denaturation of allergens.[@B138] Hypoallergenic derivatives exhibit a reduced or even abolished IgE reactivity and hence do not induce IgE-mediated side effects when administered to the patient. Immunologically, they may induce T-cell modulatory activities and the production of blocking antibodies due to the presence of T-cell and B-cell epitopes.

In addition, there are currently 2 strategies based on the use of allergen-derived peptides under investigation, which differ fundamentally in their immunological mode of action: a T-cell and a B-cell epitope approach. Regarding the first, T cell epitope-containing peptides (10-12 amino acids) are designed to lack IgE-binding epitopes and are thought to act via the induction of tolerance or anergy. Administration of such peptides in clinical studies proved the lack of IgE-mediated adverse events, but a drawback was the occurrence of late-phase reactions.[@B139],[@B140] For the second approach, peptides (20-40 amino acids) derived from IgE-binding sites on the surface of the allergen are taken and fused with an allergen-unrelated carrier molecule with the aim to induce upon immunization IgG antibodies which are directed toward IgE-binding sites on the allergen and hence block IgE binding to the natural allergen.[@B72],[@B141] They rely on the principle that peptides which are taken from the IgE-binding sites themselves do not react with IgE and therefore are unable to trigger IgE-mediated side effects. The peptides are also selected to contain as little as possible remaining allergen-specific T cell epitopes to also avoid the induction of late-phase reactions due to activation of allergen-specific T cells upon administration to the patient.[@B142],[@B143] To induce allergen-specific IgG, the allergen-derived peptides are bound to carrier molecules that provide T-cell help. In the beginning peptides were coupled chemically to KLH (keyhole limpet hemocyanin), a protein from the mollusc *Megathura crenulata* but the vaccines which are currently in clinical trial are based on recombinant fusion proteins consisting of a viral carrier proteins which are fused to the allergen peptides to facilitate reproducible large-scale production under good manufacturing practice (GMP).[@B141],[@B144] The latter strategy holds promise that vaccines can be developed which can be given as few high dose injections (3-4 per year) to patients without inducing severe systemic side effects and therefore may be particularly suitable for the treatment of mold-sensitized patients, who often suffer from severe symptoms (*e.g.*, asthma) and are at high risk of developing adverse reactions.

### Outlook: Vaccines for mold allergy

Although fungi have been underestimated allergen sources, the sequences of an increasing number of mold allergens are becoming available and in particular the major allergens from some of the most important allergenic molds have been characterized.[@B5],[@B6] Also our knowledge of IgE and T-cell epitopes of mold allergens increases. By using short synthetic peptides, IgE-binding epitopes of Alt a 1,[@B145],[@B146] Asp f 2, Cla h 6, Pen ch 13,[@B147] and Pen n 18[@B148] have been determined. Based on this information, hypoallergens or hypoallergenic derivatives can be developed. For example, deletion of amino acids from the N- and C-terminus of Asp f 2 abrogated IgE binding in sera from *Aspergillus*-sensitized patients.[@B149] A lower IgE reactivity was also obtained by site-directed mutagenesis of the *Malassezia sympodialis* allergen Mala s 11[@B150] and the *Penicillium crysogenum* allergen Pen ch 18.[@B151] The insertion of 2 mutations in an IgE-reactive fragment of Alt a 13 resulted in a mutant with reduced IgE binding and reduced allergenic activity. Stimulation of PBMCs from *Alternaria*-sensitized patients with this mutant revealed a retained T-cell reactivity with reduced production of IL-4.[@B152] We recently identified Alt a 1-derived peptides without allergenic activity, but with ability to induce Alt a 1 specific IgGs that could inhibit allergic patients\' IgE binding to Alt a 1.[@B72] Based on these results it should be possible to construct non-allergenic fusion proteins consisting of the peptides and a suitable carrier protein for the development of a safe candidate vaccine for SIT of Alternaria allergy which then can be evaluated in clinical studies. In order to advance progress in the field of mold allergy to other allergenic molds, it will be also important to identify the most relevant mold genera and their clinically relevant allergens in population studies so that the prerequisites for vaccine development are available.
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###### Allergens of Ascomycota

![](aair-7-205-s001)

  Species                           Allergen                                                               Biological function                      MW (kDa)        Prev (%)   N         r                                           Cross-reactivity to   Acc. no.
  --------------------------------- ---------------------------------------------------------------------- ---------------------------------------- --------------- ---------- --------- ------------------------------------------- --------------------- ----------
  *Alternaria alternata*            Alt a 1^153^                                                           not known                                30              93         43^154^   \+                                                                P79085-1
  47                                19^154^                                                                                                                                                                                                                
  97.6                              42^155^                                                                                                                                                                                                                
  Alt a 2^156^                      not known                                                              25                                       61.5            26^156^    \+                                                    O94095-1              
  0                                 42^155^                                                                                                                                                                                                                
  Alt a 3^157^                      heat shock protein 70                                                  85                                                                  \-                                                    P78983-1              
  Alt a 4^158^                      disulfide isomerase                                                    57                                                                  \-                                                    Q00002-1              
  Alt a 5^157,158^                  acid ribosomal protein P2                                              11                                                                  \+                                                    P42037-1              
  Alt a 6^75^                       enolase                                                                46.9                                     14.3            42^155^    \+        Cla h 6^75^                                 Q9HDT3-1              
  22                                23^75^                                                                                                          Pen c 22^159^                                                                                          
  Hev b 9^160^                                                                                                                                                                                                                                             
  37                                30^110^                                                                                                                                                                                                                
  Alt a 7^158^                      YCP4 homologue                                                         22                                                                  \+                                                    P42058                
  Alt a 8^161^                      mannitol dehydrogenase                                                 29                                       40.9            22^161^    \+        Cla h 8^161^                                P0C0Y4                
  Alt a 9^158^                      not known                                                              42                                                                  \-                                                                          
  Alt a 10^158^                     aldehyde dehydrogenase                                                 53                                                                  \+                                                    P42041                
  Alt a 12^158^                     acid ribosomal protein P1                                              11                                                                  \-                                                    P49148                
  Alt a 13^81,162^                  glutathione-S-transferase                                              26                                       82.4            17^162^    \+                                                    Q6R4B4                
  Alt a 14^110^                     Manganese-dependent superoxide dismutase                               24                                                                  \-                                                    P86254                
  Alt a 70 kDa^163^                 not known                                                              70                                                                  \-                                                                          
  Alt a NTF2^164^                   nuclear transport factor 2                                             13.7                                                                \+        Cla h NTF2^164^                             Q8NKB7                
  Alt a TCTP^165^                   translationally controlled tumor protein, histamine releasing factor   18.8                                     4               225^165^   \+        Cla h TCTP^165^                             D0MQ50                
  Hom s TCTP^165^                                                                                                                                                                                                                                          
  *Alternaria arborescens*          Alt ar 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ96
  *Alternaria argyranthemi*         Alt arg 1^166^                                                         Alt a 1 related                                                               \-                                                                Q5EZB9
  *Alternaira brassicicola*         Alt b 1^166,167^                                                       Alt a 1 related                                                               \-                                                                Q8TG05
  *Alternaira blumeae*              Alt bl 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZA8
  *Alternaria brassicae*            Alt br 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ90
  *Alternaria capsici*              Alt c 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZA1
  *Alternaria carotiincultae*       Alt ca 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZB2
  *Alternaria cetera*               Alt ce 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZC1
  *Alternaria cheiranthi*           Alt ch 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZA9
  *Alternaria cinerariae*           Alt ci 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ91
  *Alternaria conjuncta*            Alt co 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZB8
  *Alternaria crassa*               Alt cr 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZA6
  *Alternaria cucumerina*           Alt cu 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ99
  *Alternaria dauci*                Alt d 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZA7
  *Alternaria dumosa*               Alt du 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ94
  *Alternaria eryngii*              Alt e 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZ86
  *Alternaria ethzedia*             Alt et 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZB5
  *Alternaria euphorbiicola*        Alt eu 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ85
  *Alternaria japonica*             Alt j 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZ87
  *Alternaria limoniasperae*        Alt l 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZ93
  *Alternaria longipes*             Alt lo 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ95
  *Alternaria macrospora*           Alt m 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZA5
  *Alternaria metachromatica*       Alt me 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZB4
  *Alternaria mimicula*             Alt mi 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ89
  *Alternaria mouchaccae*           Alt mo 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZC0
  *Alternaria oregonensis*          Alt o 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZB6
  *Alternaria petroselini*          Alt p 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZB1
  *Alternaria photistica*           Alt ph 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZB7
  *Alternaria porri*                Alt po 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZA3
  *Alternaria pseudorostrata*       Alt ps 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZA4
  *Alternaria radicina*             Alt r 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZB3
  *Alternaria solani*               Alt s 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZA0
  *Alternaria smyrnii*              Alt sm 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZB0
  *Alternaria sonchi*               Alt so 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ92
  *Alternaria tagetica*             Alt t 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZA2
  *Alternaria tenuissima*           Alt te 1^166^                                                          Alt a 1 related                                                               \-                                                                Q5EZ97
  *Aspergillus flavus*              Asp fl 13^168,169^                                                     alkaline serine protease, elastase       34                                   \+                                          Pen c 1^169^          Q9UVU3
  Pen ch 13^170^                                                                                                                                                                                                                                           
  Asp fl 18^171^                    vacuolar serine protease                                               34                                                                  \-                                                                          
  *Aspergillus fumigatus*           Asp f 1^172,173^                                                       ribonuclease                             18              46         35^174^   \+                                          Asp r 1^172^          P67875
  Asp f 2^175^                      fibrinogen binding protein                                             37                                                                  \+                                                    P79017                
  Asp f 3^176^                      peroxisomal membrane protein                                           18.5                                     49              35^174^    \+        Candida peroxisomal membrane protein^176^   O43099                
  72                                89^176^                                                                                                                                                                                                                
  62.5                              8^177^                                                                                                                                                                                                                 
  Asp f 4^178^                      not known                                                              30                                       0               35^174^    \+                                                    O60024                
  Asp f 5^179,180^                  metalloproteases                                                       42                                       74              35^174^    \+                                                    P46075                
                                    Asp f 6^181^                                                           manganese superoxide dismutase           26.7            0          35^174^   \+                                          Hom s MnSOD^181^      Q92450
                                    Asp f 7^174^                                                           not known                                11.6            29         35^174^   \+                                                                O42799
                                    Asp f 8^182^                                                           60S acidic ribosomal protein P2          11              8          75182     \+                                          Hom s P2^182^         Q9UUZ6
                                    Asp f 9^174^                                                           glycosyl hydrolase                       34              31         35^174^   \+                                                                Q8J0P4
                                    Asp f 10^183^                                                          aspartic protease                        34.4            3          35^174^   \+                                                                P41748
                                    Asp f 11^65,80^                                                        rotamase, cyclophilin                    21              90         30^80^    \+                                          Hom s CyP B^66^       Q9Y7F6
                                                                                                                                                                                                                                     Mala s 6^80^          
                                    Asp f 12^184^                                                          heat shock protein 90                    90                                   \+                                                                P40292
                                    Asp f 13^179,185-187^                                                  alkaline serine protease                 33                                   \+                                                                P28296
                                    Asp f 15^188^                                                          serine protease                          16                                   \-                                                                O60022
                                    Asp f 16^189^                                                          not known                                43                                   \+                                                                Q8J0P4
                                    Asp f 17                                                               not known                                                                     \-                                                                O60025
                                    Asp f 18^190^                                                          vacuolar serine protease                 34                                   \+                                                                P87184
                                    Asp f 22^159^                                                          enolase                                  47                                   \+                                          Alt a 6^159^          Q96X30
                                                                                                                                                                                                                                     Pen c 22^159^         
                                    Asp f 23^191^                                                          60S ribosomal protein L3                 44                                   \+                                                                Q8NKF4
                                    Asp f 27^66^                                                           cyclophilin                              17.7                                 \+                                          Hom s CyP B^66^       Q4WWX5
                                    Asp f 28^67^                                                           thioredoxin                              11.9                                 \+                                          Mala s 13^67^         Q1RQJ1
                                    Asp f 29^67^                                                           thioredoxin                              12                                   \+                                          Mala s 13^67^         Q4WV97
                                    Asp f 34^192^                                                          PhiA cell wall protein                   19.3            46         24^192^   \+                                                                A4FSH5
                                    Asp f 56 kDa^193^                                                      protease                                 56                                   \-                                                                
                                    Asp f AfCalAp^194^                                                     extracellular thaumatin domain protein   18.7                                 \+                                                                
                                    Asp f GST^81^                                                          glutathione S-transferase                26                                   \-                                                                B0Y813
  *Aspergillus nidulans*            Aspe ni 2^195^                                                         not known                                29                                   \+                                                                Q00746
  *Aspergillus niger*               Asp n 14^196^                                                          β-xylosidase                             105                                  \-                                                                O00089
  Asp n 18^197^                     vacuolar serine protease                                               34                                                                  \+                                                    P33295                
  Asp n 25^198,199^                 phosphatase                                                            66                                                                  \-                                                    P34754                
  Asp n 30^200^                     catalase                                                               84.2                                                                \-                                                    A2QTS7                
  Asp n Glucoamylase^201^           glucoamylase                                                           68.3                                                                \-                                                    P69328                
  Asp n Hemicellulase^202,203^      hemicellulase                                                          22.6                                                                \+                                                    P55329                
  Asp n Pectinase                   polygalacturonases                                                     38.1                                                                \-                                                    P26213                
  *Aspergillus oryzae*              Asp o 13^204,205^                                                      alkaline serine protease                 34                                   \+                                                                P12547
                                    Asp o 21^206^                                                          TAKA amylase A                           53                                   \-                                                                P0C1B4
                                    Asp o Lactase^207,208^                                                 galactosidase                            109                                  \-                                                                
  Asp o Lipase^209^                 lipase                                                                 31                                                                  \-                                                                          
  *Aspergillus restrictus*          Asp r 1^210,211^                                                       ribonuclease                             18                                   \-                                                                P67876
  *Aspergillus versicolor*          Asp v 13^212^                                                          Extracellular alkaline serine proteas    43                                   \+                                                                D5LGB3
  Asp v Catalase A (Asp v 5)^213^   catalase                                                               105                                                                 \-                                                                          
  Asp v Enolase (Asp f 7)^213^      enolase                                                                58                                                                  \-                                                                          
  Asp v GAPDH (Aspf v 1)^213^       glyceraldehyde-3-phosphate                                             35                                                                  \+                                                                          
  dehydrogenase                                                                                                                                                     \-                                                                                     
  Asp v MDH (Asp v 9)^213^          malate dehydrogenase                                                   33                                                                  \-                                                                          
  Asp v SXR (Asp v 4)^213^          sorbitol/xylulose reductase                                            27                                                                  \-                                                                          
  *Beauveria bassiana*              Bea b Ald^214^                                                         aldehyde dehydrogenase                   53.9                                 \+                                                                Q0PV91
  Bea b Enol^214^                   enolase                                                                47.4                                                                \+                                                    Q0PV93                
  Bea b f2^214^                     fibrinogen binding protein                                             28.6                                                                \+                                                    Q0PV92                
  Bea b Hex^214^                    N-acetylglucosaminidase                                                72                                                                  \+                                                    Q0PV90                
  *Candida albicans*                Cand a 1^215,216^                                                      alcohol dehydrogenase                    40                                   \-                                                                P43067
  Cand a 3^217^                     peroxisomal membrane protein                                           29                                                                  \+                                                    Q6YK78                
  Cand a CAAP^218^                  acid protease                                                          44                                       36.7            49^219^    \-                                                                          
  Cand a CyP^80^                    rotamase, cyclophilin                                                  18                                                                  \+                                                                          
  Cand a Enolase^220-223^           enolase                                                                46                                       37              54^77^     \+        Sac c Enolase^77^                           P30575                
  Rho m1^76^                                                                                                                                                                                                                                               
  Cand a FPA^220^                   fructose 1,6- bisphosphate aldolase                                    37                                                                  \-                                                    Q9URB4                
  Cand a PGK^220,224^               phosphoglycerate kinase                                                43                                                                  \-                                                    P46273                
  *Candida boidinii*                Cand b 2^225^                                                          peroxisomal membrane protein             18.6                                 \+                                          Asp f 3^176^          P14292
  Cand b FD^226^                    formate dehydrogenase                                                  40.3                                                                \-                                                    O93968                
  *Cladosporium cladosporioides*    Cla c 9^227^                                                           vacuolar serine protease                 36                                   \+                                          Asp f 18^227^         B0L807
  Pen ch 18^227^                                                                                                                                                                                                                                           
  Cla c 14^228^                     transaldolase                                                          36.5                                     38              10         \+        Pen ch 35^228^                              G8Z407                
  *Cladosporium herbarum*           Cla h 1^158^                                                           not known                                30                                   \-                                                                
  Cla h 2 \[123, 192\] ^158,229^    not known                                                              45                                                                  \-                                                                          
  Cla h 5 \[123, 193\] ^158,230^    acid ribosomal protein P2                                              11                                                                  \+                                                    P42039                
  Cla h 6 \[123\] 158               enolase                                                                46                                                                  \+        Alt a 6^75^                                 P42040                
  Sac c Enolase^75^                                                                                                                                                                                                                                        
  Hev b 9^160^                                                                                                                                                                                                                                             
  Cla h 7^158^                      flavodoxin (YCP4 homologue)                                            22                                                                  \+                                                    P42059                
  Cla h 8^231^                      mannitol dehydrogenase                                                 28                                       57.1            21^231^    \+        Alt a 8^161^                                P0C0Y5                
  Cla h 9^232^                      vacuolar serine protease                                               55                                       15.5            110^232^   \+        Asp f 18^232^                               B7ZK61                
  Pen ch 13^232^                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                     Pen o 18232           
  Cla h 10^158^                     aldehyde dehydrogenase                                                 53                                                                  \+                                                    P40108                
  Cla h 12                          acid ribosomal protein P1                                              11                                                                  \-                                                    P50344                
  Cla h abH^223^                    alpha/beta hydrolase                                                   29.9                                     17.9            28^233^    \+                                                                          
  Cla h 8 CSP^234^                  cold shock protein                                                     8                                                                   \+                                                                          
  Cla h 42 kDa^158^                 not known                                                              42                                                                  \-                                                                          
  Cla h GST^81^                     glutathione S-transferase                                              26                                                                  \-                                                                          
  Cla h HCh1^235^                   hydrophobin-1                                                          10.5                                                                \+                                                    Q8NIN9                
  Cla h HSP70^236^                  heat shock protein                                                     70                                                                  \+                                                    P40918                
  Cla h NTF2^164^                   nuclear transport factor 2                                             14.2                                                                \+        Alt a NTF2^164^                             Q8NJ52                
  Cla h TCTP^237^                   translationally controlled tumor protein, histamine releasing factor   18.7                                     3               306^237^   \+        Alt a TCTP^165^                             A1KXP4                
  Hom s TCTP^165,237^                                                                                                                                                                                                                                      
  *Cryphonectria parasitica*        Cry p Aspartic Protease^238^                                           aspartic protease                        43.2                                 \-                                                                P11838
  *Curvularia lunata*               Cur l 1^239^                                                           serine protease                          31              80         15^239^   \-                                                                
  Cur l 2^240^                      enolase                                                                48                                       100             15^240^    \+                                                    Q96VP4                
  Cur l 3^241^                      cytochrome C                                                           12                                       66.7-100        15^241^    \+        Proteins of                                 Q96VP3                
  *Alternaria alternata*^241^                                                                                                                                                                                                                              
  *Cladosporium herbarum*^241^                                                                                                                                                                                                                             
  *Fusarium solani*^241^                                                                                                                                                                                                                                   
  *Epicoccum purpurascens*^241^                                                                                                                                                                                                                            
  *Aspergillus fumigatus*^241^                                                                                                                                                                                                                             
  *Rhizopus oryzae*^241^                                                                                                                                                                                                                                   
  *Mucor hiemalis*^241^                                                                                                                                                                                                                                    
  *Penicillium citrinum*^241^                                                                                                                                                                                                                              
  *Candida albicans*^241^                                                                                                                                                                                                                                  
  *Lolium perenne*^241^                                                                                                                                                                                                                                    
  *Phleum pratense*^241^                                                                                                                                                                                                                                   
  *Poa pratensis*^241^                                                                                                                                                                                                                                     
  *Imperata cylindrica*^241^                                                                                                                                                                                                                               
  *Zea mays*^241^                                                                                                                                                                                                                                          
  *Pennisetum tyhpoides*^241^                                                                                                                                                                                                                              
  *Cenchrus ciliaris*^241^                                                                                                                                                                                                                                 
  Cur l 4^242^                      vacuolar serine protease                                               54                                       81              16^242^    \+                                                    B3V0K8                
  Cur l ADH                         alcohol dehydrogenase                                                  37.6                                                                \-                                                    A1YDT6                
  Cur l GST^81^                     glutathione-S-transferase                                              26.9                                                                \-                                                    Q45X98                
  Cur l MnSOD                       Mn superoxide dismutase                                                21.4                                                                \-                                                    Q1EHH3                
  Cur l Oryzin                      oryzin, Asp f 13-like protein                                          14.2                                                                \-                                                    Q1EHH2                
  Cur l Trx                         thioredoxin, Cop c 2-like protein                                      12.3                                                                \-                                                    Q1EHH0                
  Cur l ZPS1                        Asp f 2-like protein                                                   17.3                                                                \-                                                    Q1EHH4                
  *Embellisia allii*                Emb a 1^166^                                                           Alt a 1 related                                                               \-                                          AY563322              
  *Embellisia indefessa*            Emb i 1^166^                                                           Alt a 1 related                                                               \-                                          AY563323              
  *Embellisia novae-zelandiae*      Emb nz 1^166^                                                          Alt a 1 related                                                               \-                                          AY563324              
  *Embellisia telluster*            Emb t 1^166^                                                           Alt a 1 related                                                               \-                                          AY563325              
  *Epicoccum purpurascens*          Epi p 1^243,244^                                                       serine protease                          33.5                                 \-                                                                P83340
  *(Epicoccum nigrum)*              Epi p GST^81^                                                          glutathione-S-transferase                26                                   \-                                                                Q45X97
  *Fusarium culmorum*               Fus c 1^245^                                                           60S acid ribosomal protein P2            11              35         26^245^   \+                                                                Q8TFM9
  Fus c 2^245^                      thioredoxin-like protein                                               13                                       50              26^245^    \+                                                    Q8TFM8                
  Fus c 3^245^                      not known                                                              49                                       15              26^245^    \+                                                    Q8J1X7                
  *Fusarium proliferatum*           Fus p 4^83^                                                            transaldolase                            37.5            47         17^245^   \+                                                                
  *Fusarium solani*                 Fus s 1^246^                                                           not known                                65                                   \-                                                                P81010
  Fus s 45 kDa^247^                 not known                                                              45                                                                  \-        proteins from                                                     
  *Alternaria alternata*^247^                                                                                                                                                                                                                              
  *Cladosporium herbarum*^247^                                                                                                                                                                                                                             
  *Curvularia lunata*^247^                                                                                                                                                                                                                                 
  *Epicoccum nigrum*^247^                                                                                                                                                                                                                                  
  *Neosartorya fischeri*            Neo fi 1                                                               ribonuclease                             19.6                                 \-                                                                A1D080
  *Nimbya caricis*                  Nim c 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563321
  *Nimbya scirpicola*               Nim s 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563320
  *Penicillium brevicompactum*      Pen b 13^248^                                                          alkaline serine protease                 33                                   \-                                                                
  Pen b 26^249,250^                 60S acid ribosomal protein P1                                          11                                       73              41^250^    \+                                                    Q49KL9                
  *Penicillium chrysogenum*         Pen ch 13^170,251,252^                                                 alkaline serine protease                 34                                   \+                                          Asp fl 13^170^        Q9URR2
  Pen c 13^170^                                                                                                                                                                                                                                            
  Pen c 1^251^                                                                                                                                                                                                                                             
  Pen ch 18^252,253^                vacuolar serine protease                                               32                                       76.9            13^254^    \+        Cla c 9^227^                                Q9P8G3                
  Pen c 18^253^                                                                                                                                                                                                                                            
  Rho m 2^255^                                                                                                                                                                                                                                             
  Pen ch 20^256^                    N-acetyl glucosaminidase                                               68                                                                  \+                                                    Q02352                
  Pen ch 31                         calreticulin                                                           61.6                                                                \-                                                    Q2TL59                
  Pen ch 33                         not known                                                              16                                                                  \-                                                                          
  Pen ch 35^83^                     transaldolase                                                          36.5                                                                \+        Cla c 14^83^                                G8Z408                
  *Penicillium citrinum*            Pen c 1^257^                                                           alkaline serine protease                 33                                   \+                                          Pen ch 13^251^        Q9Y749
  Pen c 2^258^                      alkaline vacuolar serine protease                                      43                                                                  \+                                                    Q9Y755                
  Pen c 3^259^                      peroxisomal membrane protein                                           18                                       46.4            28^259^    \+        Asp f 3^259^                                Q9Y8B8                
  Pen c 13^170,205^                 alkaline serine protease                                               33                                                                  \+        Cla h 91                                                          
  Pen ch 13^170^                                                                                                                                                                                                                                           
  Pen c 18^260^                     vacuolar serine protease                                               37.4                                                                \+        Pen ch 18^253^                              Q9HF11                
  Pen o 18^260^                                                                                                                                                                                                                                            
  Pen c 19^261^                     heat shock protein 70                                                  70                                                                  \+                                                    Q92260                
  Pen c 22^159^                     enolase                                                                47                                       30              23^159^    \+        Asp f 22^159^                               Q96X46                
  Pen c 241                         elongation factor 1 beta                                               25                                                                  \+                                                    Q69BZ7                
  Pen c 30^263^                     catalase                                                               97                                                                  \-                                                    Q2V6Q5                
  Pen c 32^263^                     pectate lyase                                                          40                                                                  \-                                                    A2I7W3                
  Pen c MnSOD                       Mn superoxide dismutase                                                23.1                                                                \-                                                    A1YDT8                
  *Penicillium crustosum*           Pen cr 26^264^                                                         60S acidic ribosomal phosphoprotein P1   11              23                   \+                                                                H2E5X2
  *Penicillium oxalicum*            Pen o 18^260^                                                          vacuolar serine protease                 34                                   \+                                          Pen o 18^260^         Q9HF12
  *Phoma tracheiphila*              Pho t 1                                                                not known                                                                     \-                                                                
  *Pleospora herbarum*              Ple h 1^166^                                                           Alt a 1 related                                                               \-                                                                Q5EZC2
  *Saccharomyces cervisiae*         Sac c alpha Glucosidae                                                 glucosidase                              68.1                                 \-                                                                P38158
  Sac c Carboxypeptidase Y          serine carboxypeptidase                                                                                                                    \-                                                    P00729                
  Sac c Cyp^80^                     rotamase, cyclophilin                                                  18                                                                  \+                                                                          
  Sac c Enolase^265^                enolase                                                                46.7                                                                \-        Cand a enolase^77,266^                      P00924                
  Sac c Invertase                   fructofuranosidase                                                     60.6                                                                \-                                                                          
  Sac c MnSOD^267^                  manganese superoxide dismutase                                         25                                                                  \+        Asp f 6^78^                                 P00447                
  Hom s MnSOD^78^                                                                                                                                                                                                                                          
  *Stachybotrys chartarum*          Sta c 3 Shi^268,269^                                                   Mg-dependent exodesoxyribonuclease       21              83         6^268^    \+                                                                GQ258854
  Sta c Cellulase^270^              glycosyl hydrolase, cellulase                                          48                                                                  \-                                                                          
  Sta c Hemolysin^271^              hemolysin                                                              30                                       38              21^271^    \-                                                                          
  Sta c Stachyrase A^271,272^       chymotrypsin-like serine protease                                      32                                       81              21^271^    \-                                                                          
  SchS3^468^                                                                                               34                                                       4^68^      \+                                                    GQ258855              
  *Stemphylium botroyosum*          Ste b 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563274
  *Stemphylium callistephi*         Ste c 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563276
  *Stemphylium vesicarium*          Ste v 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563275
  *Thermomyces lanuginosus*         The l Lipase^273^                                                      lipase                                                                        \-                                                                O59952
  *Thermomyces mentagrophytes*      Tri me 2                                                               serine protease                                                               \-                                                                Q8J1L9
  Tri me 4                          dipeptidyl peptidase                                                   80                                                                  \-                                                    Q8J1M3                
  *Trichophyton rubrum*             Tri r 2^274,275^                                                       subtilisin-like serine protease          29              43         73^275^   \+                                                                Q9UW97
  Tri r 4^274,275^                  serine protease                                                        83                                                                  \+                                                    Q9UW98                
  *Trichophyton schoenleinii*       Tri sc 2                                                               dipeptidyl-peptidase                     80                                   \-                                                                Q8J077
  Tri sc 4                                                                                                                                                                     \-                                                    Q8J1L4                
  *Trichophyton tonsurans*          Tri t 1^276^                                                           not known                                30              54         48^276^   \-                                                                
  73                                30^276^                                                                                                                                                                                                                
  Tri t 4^277^                      serine protease                                                        83                                       56.5            23^277^    \-                                                    P80514                
  *Ulocladium alternariae*          Ulo a 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563316
  *Ulocladium atrum*                Ulo at 1^166^                                                          Alt a 1 related                                                               \-                                                                AY563318
  *Ulocladium botrytis*             Ulo b 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563317
  *Ulocladium chartarum*            Ulo c 1^166^                                                           Alt a 1 related                                                               \-                                                                AY563319
  *Ulocladium cucurbitae*           Ulo cu 1^166^                                                          Alt a 1 related                                                               \-                                                                AY563315

###### Allergens of Basidiomycota

![](aair-7-205-s002)

  Species                      Allergen                                 Biological function            MW (kDa)          Prev (%)   N         r                  Cross-reactivity to       Acc. no.
  ---------------------------- ---------------------------------------- ------------------------------ ----------------- ---------- --------- ------------------ ------------------------- ----------
  *Coprinus comatus*           Cop c 1^278^                             leucin zipper protein          11                25         92        \+                                           Q9Y7G3
  Cop c 2                      thioredoxin                              11.8                                                        \-                           Q9UW02                    
  Cop c 3                      not known                                                                                            \-                           Q9UW01                    
  Cop c 4                      not known                                                                                            \-                                                     
  Cop c 5                      not known                                15.6                                                        \-                           Q9UW00                    
  Cop c 6                      not known                                                                                            \-                                                     
  Cop c 7                      not known                                                                                            \-                           Q9UVZ9                    
  *Malassezia furfur*          Mala f 2^279^                            peroxisomal membrane protein   21                71.9       64^279^   \+                                           P56577
  Mala f 3^279^                peroxisomal membrane protein             20                             70.3              64^279^    \+                           P56578                    
  Mala f 4^280^                mitochondrial malate dehydrogenase       35                             83.3              36^280^    \+                           Q9Y750                    
  *Malassezia sympodialis*     Mala s 1^281^                            cell wall protein              36                43-61      95^282^   \+                                           Q01940
  17.5                         40^283^                                                                                                                                                     
  Mala s 5^284^                peroxisomal membrane protein             18.2                           48                25^284^    \+                           O93969                    
  35                           40^283^                                                                                                                                                     
  Mala s 6^284^                rotamase, cyclophilin                    17.2                           48                25^284^    \+        Asp f 11^80^       O93970                    
  40                           40^283^                                                                 Hom s CyP B^66^                                                                     
  92                           48^80^                                                                                                                                                      
  Mala s 7^285^                not known                                16.2                           40-60             25^285^    \+                           O93971                    
  Mala s 8^285^                not known                                19.2                           10-18             25^285^    \+                           O93972                    
  Mala s 9^285^                not known                                14                             24-36             25^285^    \+                           O93973                    
  Mala s 10^286^               heat shock protein                       86                             69                28^286^    \+                           Q8TGH3                    
  Mala s 11^286^               manganese superoxide dismutase           23                             75                28^286^    \+        Hom s MnSOD^287^   Q873M4                    
  Mala s 12^288^               glucose-methanol-choline oxidorecutase   67                             62                21^288^    \+                           Q5GMY3                    
  Mala s 13^67^                thioredoxin                              11.5                                                        \+        Asp f 28^67^       Q1RQI9                    
  Asp f 29^67^                                                                                                                                                                             
  Hom s Trx^67^                                                                                                                                                                            
  *Psilocybe cubensis*         Psi c 1                                  not known                                                             \-                                           
  Psi c 2^79,289^              rotamase                                 16                                                          \+                                                     
  *Rhodotorula mucilaginosa*   Rho m 1^76^                              enolase                        47                21.4       14^76^    \+                 Cand a Enolase^76^        Q870B9
  Pen c 2^276^                                                                                                                                                                             
  Rho m 2^255^                 vacuolar serine protease                 31                                                          \+        Pen ch 18^255^     Q32ZM1                    
  Pen o 18^255^                                                                                                                                                                            
  *Schizophyllum commune*      Sch c 1^290^                             glucoamylase                   61                                     \+                 Asp n Glucoamylase^290^   D8Q9M3

###### Allergens of Zygomycota

![](aair-7-205-s003)

  Species               Allergen                  Biological function   MW (kDa)   Prev (%)   N   r    Cross-reactivity to   Acc. no.
  --------------------- ------------------------- --------------------- ---------- ---------- --- ---- --------------------- ----------
  *Rhizomucor miehei*   Rhi m Aspartic Protease   aspartic protease     46.2                      \-                         P00799

Fungal species producing allergenic molecules are listed according to their classification to the phyla Ascomycota (A), Basidomycota (B) or Zygomycota (C). Allergen designations, biological functions, molecular weights (in kDa), prevalences (in %), cross-reactivities, accession numbers (Acc. no.) are displayed. N, number of patients analyzed; r, available as recombinant protein.

![Seasonal variations influence the number of spores in the atmosphere. The climatic conditions in summer and autumn favour the growth of certain fungal species and the dispersal of spores. Exceptional high concentrations of spores from the species *Alternaria* and *Cladosporium* as well as from species of the phylum Basidiomycota can be found from June to October (modified after Lacey J, 1996).](aair-7-205-g001){#F1}

![Geographical distribution of fungal allergy. Fungal allergy represents a worldwide health problem. The world map highlights in yellow all countries in which sensitization to fungi has been described.](aair-7-205-g002){#F2}

![Fungal species as a source of type I allergy. The taxonomical tree includes all allergen producing fungal species that have been approved by the I.U.I.S. Allergen Nomenclature Sub-committee (<http://www.allergen.org>).](aair-7-205-g003){#F3}

![Fungal spore seasons overlap with grass and weed pollen seasons. Diagnosis of fungal allergy is complicated by the fact that mould allergic patients are often polysensitized. Exacerbated allergic symptoms in summer and autumn might be due to fungal allergy, but can also arise from allergy to grasses and weeds like mugwort (*Artemisia*), ragweed (*Ambrosia*) or Parietaria. The intensity of allergen exposure to grasses, weeds and moulds is displayed in red for high exposure, orange for intermediate exposure and yellow for low exposure.](aair-7-205-g004){#F4}

![Influence of strain variabilities and growth conditions on the presence of IgE binding proteins in extracts of *Alternaria alternata*. Four *Alternaria strains*, achieved by the Centraalbureau voor Schimmelcultures (CBS 103.33, CBS 795.72) and the American Type Culture Collection (ATCC 46582 and ATCC 96154) were grown on 3 different media (C, Czapek Dox agar; ME, Malt Extract agar; S, Sabauroud agar) for 2 or 4 weeks respectively. Protein extracts of the fungi were subjected to SDS-PAGE, blotted onto nitrocellulose membranes and incubated with the serum of an *Alternaria*-sensitized patient. Bound IgE antibodies were detected with ^125^I-labelled anti-human IgE antibodies and visualized by autoradiography](aair-7-205-g005){#F5}

###### Immunotherapy studies with fungal extracts

![](aair-7-205-i001)

  Design of study           Mould species                                          Schedule            No. of patients   Side-effects   Withdrawal due to side-effects   Ref.   
  ------------------------- ------------------------------------------------------ ------------------- ----------------- -------------- -------------------------------- ------ -------------
  Retrospective             *Alternaria alternata*                                 SIT, cluster        52                1              3                                1      \[[@B121]\]
  SIT, conventional short   42                                                     4                   2                                                                        
  Retrospective             *Alternaria tenuis*                                    SIT, cluster        108                                                               0      \[[@B120]\]
  4 visits/10 injections    60                                                     1                   2                                                                        
  4 visits/8 injections     9                                                      0                   0                                                                        
  3 visits/9 injections     6                                                      0                   0                                                                        
  3 visits/6 injections     33                                                     0                   0                                                                        
  Retrospective             *Alternaria tenuis*                                    SIT, conventional   129               3              48                               n.k.   \[[@B119]\]
  Prospective               *Alternaria iridis/alternata*                          SIT, conventional   13                n.k.           n.k.                             4      \[[@B117]\]
  *Cladosporium herbarum*   13                                                     n.k.                n.k.              9                                                      
  Prospective               *Alternaria iridis mixed with Cladosporium herbarum*   SIT, conventional   38                n.k.           n.k.                             7      \[[@B116]\]

SIT, Specific immunotherapy.

###### Immunotherapy studies with fungal extracts

![](aair-7-205-i002)

  Design of study   Mould species     Schedule            No. of patients active/placebo   Clinical effect                      Immunological effects     Side-effects   Ref.   
  ----------------- ----------------- ------------------- -------------------------------- ------------------------------------ ------------------------- -------------- ------ -------------------------------------
  DB, PC            *C. herbarum*     SIT, cluster        16/14                            medication score↓                    IgE↓, IgG↑                4^\*^          13     \[[@B122],[@B123]\]
                                                                                           bronchial sensitivity↓                                                               
  DB, PC            *C. herbarum*     SIT, cluster        11/11                            symptom medication score↓            IgE↓                      8              11     \[[@B124],[@B125],[@B126],[@B127]\]
                                                                                           PEF↑                                 IgG~1~ and IgG~4~↑                              
                                                                                           skin reactivity↓                                                                     
  DB, PC            *Alternaria*sp.   SIT, rush           13/11                            global symptom medication score↓     IgG↑                      0              2      \[[@B128]\]
                                                                                           skin reactivity↓                                                                     
                                                                                           nasal tolerance↑                                                                     
  DB, PC            *A. alternata*    SLIT                19/20                            symptom medication score↓            IgG~4~↑                                  8      \[[@B129]\]
                                                                                           skin reactivity↓                                                                     
                                                                                           respiratory tolerance↑ (challenge)                                                   
  DB, PC            *A. alternata*    SIT, conventional   14/14                            conjunctival sensitivity↓            IgE↓                      0              2      \[[@B131],[@B132]\]
                                                                                           PEF↑                                 IgG, IgG~1~ and IgG~4~↑                         
  DB, PC            *A. alternata*    SIT, conventional   30/20                            symptom medication score↓            IgE↓                      7              0      \[[@B133]\]
                                                                                           nasal tolerance↑                                                                     
  Case control      *A. tenuis*       SIT, conventional   39/40                            symptom score↓                       n.k.                      \+             0      \[[@B134]\]
                                                                                           medication score↓                                                                    
  Open control      *A. tenuis*       SIT, conventional   11                               skin reactivity↓                     IgE↓                      2              2      \[[@B39]\]
                                                                                           symtom score↓                        IgG and IgG~4~↑                                 
                                                                                           medication score↓                                                                    
                                      SLIT                12                               symtom score↓                                                  0              0      \[[@B39]\]
                                                                                           medication score↓                                                                    
                                                                                           nasal tolerance↑                                                                     
  Open control      *A. alternata*    SIT, conventional   9/7                              bronchial sensitivity↓               IgE↓                                            \[[@B135]\]

^\*^number of reactions.

n.k., not known; DB, PC, double blind placebo-controlled; *C. herbarum*, *Cladosporium herbarum*; *Alternaria* sp., *Alternaria* species; *A. alternata*, *Alternaria alternata*; *A. tenuis*, *Alternaria tenuis*; SIT, subcutaneous immunotherapy; SLIT, sublingual immunotherapy; PEF, peak expiratory flow.
